Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal By: CNBC.com News August 01, 2023 at 06:32 AM EDT Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S. Read More >> Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal By: CNBC.com News August 01, 2023 at 06:32 AM EDT Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S. Read More >>
